Target Name: NPPA
NCBI ID: G4878
Review Report on NPPA Target / Biomarker Content of Review Report on NPPA Target / Biomarker
NPPA
Other Name(s): Auriculin-B | cardionatrin | CDD 95-126 | Urodilatin | Vessel dilator | N-terminal proatrial natriuretic peptide | Cardiodilatin | CDD-ANP (99-126) | Pro atrial natriuretic peptide 79-98 | Cardionatrin | Pro atrial natriuretic factor 31-67 | CDD-ANP (95-126) | natriuretic peptide precursor A | ANF_HUMAN | ANP | atriopeptigen | Atrial natriuretic factor 8-33 | atriopeptin | Atrial natriuretic factor | proANP 1-30 | Atriopeptin III | Alpha-hANP | Atriopeptin-2 | proANP 79-98 | ANF 1-33 | Pro atrial natriuretic factor 99-126 | proANF 31-67 | ATRST2 | Prepronatriodilatin | proANP | Long-acting natriuretic hormone | Atrial natriuretic factor 1-33 | LANP | Pro atrial natriuretic peptide 31-67 | Pro atrial natriuretic factor 1-30 | PND | proANF 99-126 | Natriuretic peptide A | prepronatriodilatin | Auriculin-C | Pro atrial natriuretic peptide 1-30 | preproCDD-ANF | Atrial natriuretic factor prohormone | CDD | Atrial natriuretic peptide (alpha-ANP) | N-ANP | Auriculin-A | KP | atrial natriuretic peptide prohormone | Atriopeptigen | LANH | Atriopeptin-3 | Cardiodilatin-related peptide | Atrial natriuretic peptide prohormone | Kaliuretic peptide | Alpha-atrial natriuretic peptide | ATFB6 | CDP | proANF 1-30 | atrial natriuretic factor prohormone | Pro atrial natriuretic peptide 95-126 | URO | VSDL | ANF | proANP(1闂?8) | natriuretic peptide A | ANF 8-33 | Atriopeptin | Auriculin-D | Pro atrial natriuretic factor 79-98 | Atrial natriuretic factor 3-33 | CDD-ANF | cardiodilatin-related peptide | proANF 79-98 | Atriopeptin-1 | long-acting natriuretic peptide | proANP 95-126 | NT-proANP_(HUMAN) | Atrial natriuretic peptide | Natriuretic peptides A | preproANP | Natriuretic peptide precursor A | proANP 31-67 | ANF 3-33 | Atriopeptin I | Atriopeptin II | proANF | natriuretic peptide precursor A variant 1 | Long-acting natriuretic peptide

NPPA's Role in Cell Growth and Differentiation

NPPA (N-acetyl-p-valine), also known as Aurorain, is a protein that is expressed in various tissues throughout the body. It is a key player in the regulation of cell growth and differentiation, and is often used as a drug target or biomarker for various diseases.

NPPA has been shown to play a crucial role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its role in these processes is often related to its ability to regulate cell proliferation and survival, as well as its role in the regulation of cell signaling pathways.

One of the key functions of NPPA is its ability to inhibit the inhibition of cell proliferation. This is accomplished through the inhibition of the protein p53, which is a well-known tumor suppressor protein that plays a critical role in the regulation of cell growth and differentiation. By inhibiting the activity of p53, NPPA allows cells to continue to divide and proliferate, leading to the development of cancer.

In addition to its role in cell proliferation, NPPA is also involved in the regulation of cell apoptosis, which is the process by which cells die and are removed from the body. Studies have shown that NPPA plays a key role in the regulation of cell apoptosis, and is often used as a biomarker for various diseases, including cancer.

NPPA's involvement in cell apoptosis is related to its ability to interact with the protein Bcl-2, which is a protein that is involved in the regulation of cell apoptosis. Studies have shown that NPPA and Bcl-2 can interact and work together to regulate cell apoptosis. This interaction between NPPA and Bcl-2 is thought to be a key factor in the regulation of cell apoptosis and may have implications for the development of cancer.

In addition to its role in cell proliferation and apoptosis, NPPA is also involved in the regulation of cell signaling pathways. This is accomplished through its ability to interact with various signaling proteins, including the protein TGF-β. TGF-β is a well- Known protein that is involved in the regulation of cell growth and differentiation, and is often used as a drug target or biomarker for various diseases.

The role of TGF-β in the regulation of cell growth and differentiation is related to its ability to interact with the protein SMAD4, which is a protein that is involved in the regulation of cell signaling pathways. Studies have shown that TGF-β and SMAD4 can interact and work together to regulate cell growth and differentiation. This interaction between TGF-β and SMAD4 is thought to be a key factor in the regulation of cell growth and differentiation and may have implications for the development of various diseases.

In conclusion, NPPA is a protein that is involved in the regulation of cell growth and differentiation, and is often used as a drug target or biomarker for various diseases. Its role in these processes is related to its ability to inhibit the inhibition of cell proliferation , regulate cell apoptosis, and interact with signaling proteins like TGF-β and SMAD4. Further research is needed to fully understand the role of NPPA in the regulation of cell growth and differentiation, and to develop better treatments for various diseases.

Protein Name: Natriuretic Peptide A

Functions: Hormone that plays a key role in mediating cardio-renal homeostasis, and is involved in vascular remodeling and regulating energy metabolism (PubMed:8653797, PubMed:7595132, PubMed:2825692, PubMed:7720651, PubMed:8087923, PubMed:2532366, PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263, PubMed:16875975). Acts by specifically binding and stimulating NPR1 to produce cGMP, which in turn activates effector proteins, such as PRKG1, that drive various biological responses (PubMed:25401746, PubMed:9893117, PubMed:1672777, PubMed:1660465, PubMed:2162527, PubMed:2825692, PubMed:7720651, PubMed:22307324, PubMed:8384600, PubMed:21098034). Regulates vasodilation, natriuresis, diuresis and aldosterone synthesis and is therefore essential for regulating blood pressure, controlling the extracellular fluid volume and maintaining the fluid-electrolyte balance (PubMed:8653797, PubMed:7595132, PubMed:2825692, PubMed:7720651, PubMed:2532366, PubMed:8087923). Also involved in inhibiting cardiac remodeling and cardiac hypertrophy by inducing cardiomyocyte apoptosis and attenuating the growth of cardiomyocytes and fibroblasts (PubMed:16875975). Plays a role in female pregnancy by promoting trophoblast invasion and spiral artery remodeling in uterus, and thus prevents pregnancy-induced hypertension (By similarity). In adipose tissue, acts in various cGMP- and PKG-dependent pathways to regulate lipid metabolism and energy homeostasis (PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263). This includes up-regulating lipid metabolism and mitochondrial oxygen utilization by activating the AMP-activated protein kinase (AMPK), and increasing energy expenditure by acting via MAPK11 to promote the UCP1-dependent thermogenesis of brown adipose tissue (PubMed:22307324, PubMed:18835931, PubMed:21672517, PubMed:15741263). Binds the clearance receptor NPR3 which removes the hormone from circulation (PubMed:1672777)

The "NPPA Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NPPA comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1 | NRSN2 | NRSN2-AS1 | NRTN | NRXN1 | NRXN2 | NRXN2-AS1 | NRXN3 | NSA2 | NSA2P2 | NSD1 | NSD2